Literature DB >> 32453411

The effectiveness of full and partial travel bans against COVID-19 spread in Australia for travellers from China during and after the epidemic peak in China.

Valentina Costantino1, David J Heslop2, C Raina MacIntyre1.   

Abstract

BACKGROUND: Australia implemented a travel ban on China on 1 February 2020, while COVID-19 was largely localized to China. We modelled three scenarios to test the impact of travel bans on epidemic control. Scenario one was no ban; scenario two and three were the current ban followed by a full or partial lifting (allow over 100 000 university students to enter Australia, but not tourists) from the 8th of March 2020.
METHODS: We used disease incidence data from China and air travel passenger movements between China and Australia during and after the epidemic peak in China, derived from incoming passenger arrival cards. We used the estimated incidence of disease in China, using data on expected proportion of under-ascertainment of cases and an age-specific deterministic model to model the epidemic in each scenario.
RESULTS: The modelled epidemic with the full ban fitted the observed incidence of cases well, predicting 57 cases on March 6th in Australia, compared to 66 observed on this date; however, we did not account for imported cases from other countries. The modelled impact without a travel ban results in more than 2000 cases and about 400 deaths, if the epidemic remained localized to China and no importations from other countries occurred. The full travel ban reduced cases by about 86%, while the impact of a partial lifting of the ban is minimal and may be a policy option.
CONCLUSIONS: Travel restrictions were highly effective for containing the COVID-19 epidemic in Australia during the epidemic peak in China and averted a much larger epidemic at a time when COVID-19 was largely localized to China. This research demonstrates the effectiveness of travel bans applied to countries with high disease incidence. This research can inform decisions on placing or lifting travel bans as a control measure for the COVID-19 epidemic. © International Society of Travel Medicine 2020. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Pandemic; SARS-CoV-2; boarder closure; border quarantine; coronavirus; epidemic control; immunity password; modelling; non-pharmaceutical interventions; outbreak response; travel restrictions

Mesh:

Year:  2020        PMID: 32453411      PMCID: PMC7313810          DOI: 10.1093/jtm/taaa081

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  27 in total

1.  Recently spreading human monkeypox virus infection and its transmission during COVID-19 pandemic period: A travelers' prospective.

Authors:  Manojit Bhattacharya; Kuldeep Dhama; Chiranjib Chakraborty
Journal:  Travel Med Infect Dis       Date:  2022-06-29       Impact factor: 20.441

Review 2.  Non-pharmaceutical interventions during the COVID-19 pandemic: A review.

Authors:  Nicola Perra
Journal:  Phys Rep       Date:  2021-02-13       Impact factor: 25.600

3.  Strategies at points of entry to reduce importation risk of COVID-19 cases and reopen travel.

Authors:  Borame L Dickens; Joel R Koo; Jue Tao Lim; Haoyang Sun; Hannah E Clapham; Annelies Wilder-Smith; Alex R Cook
Journal:  J Travel Med       Date:  2020-12-23       Impact factor: 8.490

Review 4.  COVID-19: breaking down a global health crisis.

Authors:  Saad I Mallah; Omar K Ghorab; Sabrina Al-Salmi; Omar S Abdellatif; Tharmegan Tharmaratnam; Mina Amin Iskandar; Jessica Atef Nassef Sefen; Pardeep Sidhu; Bassam Atallah; Rania El-Lababidi; Manaf Al-Qahtani
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-05-18       Impact factor: 3.944

5.  Could COVID-19 pandemic be stopped with joint efforts of travel restrictions and public health countermeasures? A modelling study.

Authors:  Lingcai Kong; Yi Hu; Qiang Wang; Xinda Chen; Tong Yao; Yu Wang; Hui Jin; Lijun Fan; Wei Du
Journal:  BMJ Open       Date:  2021-05-24       Impact factor: 2.692

Review 6.  Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence.

Authors:  Sayeeda Rahman; Maria Teresa Villagomez Montero; Kherie Rowe; Rita Kirton; Frank Kunik
Journal:  Expert Rev Clin Pharmacol       Date:  2021-05-03       Impact factor: 5.045

7.  Evidence of the effectiveness of travel-related measures during the early phase of the COVID-19 pandemic: a rapid systematic review.

Authors:  Karen Ann Grépin; Tsi-Lok Ho; Zhihan Liu; Summer Marion; Julianne Piper; Catherine Z Worsnop; Kelley Lee
Journal:  BMJ Glob Health       Date:  2021-03

8.  International travel-related control measures to contain the COVID-19 pandemic: a rapid review.

Authors:  Jacob Burns; Ani Movsisyan; Jan M Stratil; Renke Lars Biallas; Michaela Coenen; Karl Mf Emmert-Fees; Karin Geffert; Sabine Hoffmann; Olaf Horstick; Michael Laxy; Carmen Klinger; Suzie Kratzer; Tim Litwin; Susan Norris; Lisa M Pfadenhauer; Peter von Philipsborn; Kerstin Sell; Julia Stadelmaier; Ben Verboom; Stephan Voss; Katharina Wabnitz; Eva Rehfuess
Journal:  Cochrane Database Syst Rev       Date:  2021-03-25

9.  Australian Quarantine Policy: From Centralization to Coordination with Mid-Pandemic COVID-19 Shifts.

Authors:  Kim Moloney; Susan Moloney
Journal:  Public Adm Rev       Date:  2020-06-29

10.  International travel during the COVID-19 pandemic: implications and risks associated with 'travel bubbles'.

Authors:  Khan Sharun; Ruchi Tiwari; SenthilKumar Natesan; Mohd Iqbal Yatoo; Yashpal Singh Malik; Kuldeep Dhama
Journal:  J Travel Med       Date:  2020-12-23       Impact factor: 8.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.